Css LLC Takeda Pharmaceutical CO LTD Call Options Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $291,280 - $328,064	-17,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $4.1 Million - $4.89 Million	-245,525 Reduced 93.31%	17,600 $321,000
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $570,969 - $703,787	-37,100 Reduced 12.36%	263,125 $4.79 Million
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $141,930 - $159,277	-8,300 Reduced 2.69%	300,225 $5.36 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $1.01 Million - $1.34 Million	68,900 Added 28.75%	308,525 $5.53 Million
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $455,700 - $710,850	35,000 Added 17.1%	239,625 $3.64 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $1.71 Million - $2.11 Million	101,180 Added 97.81%	204,625 $4.04 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $518,414 - $577,479	-32,100 Reduced 23.68%	103,445 $1.78 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $569,854 - $704,241	34,370 Added 33.97%	135,545 $2.4 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $1.69 Million - $2.18 Million	101,175 New	101,175 $2.06 Million

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $46.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.